| Pharmaceutical active ingredients: |
| ChlorthalidoneMetoprolol Tartrate |
| Available forms, composition and doses of Lopressidone: |
| Capsules; Oral; Chlorthalidone 25 mg; Metoprolol Tartrate 100 mgCapsules; Oral; Chlorthalidone 25 mg; Metoprolol Tartrate 200 mg |
| Lopressidone medical category: |
| Human |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| C07BB02 - Metoprolol and thiazides |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Novartis |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Igroton-Lopresor | Chlorthalidone; Metoprolol Tartrate | Novartis |
| Logroton | Chlorthalidone; Metoprolol Tartrate | Novartis; Recipe, Austria; Sankyo |
| Logroton Divitabs | Chlorthalidone; Metoprolol Tartrate | Novartis; Zuellig Pharma |
| Logroton Retard | Chlorthalidone; Metoprolol Tartrate | Novartis; Zuellig Pharma |
| Lopresoretic | Chlorthalidone; Metoprolol Tartrate | Novartis |
| Prelis Comp | Chlorthalidone; Metoprolol Tartrate | Novartis; Mibe Arzneimittel |
| Slow-Trasitensin | Chlorthalidone; Oxprenolol Hydrochloride | Novartis |
| Slow-Trasitensine | Chlorthalidone; Oxprenolol Hydrochloride | Novartis |
| Trasitensin | Chlorthalidone; Oxprenolol Hydrochloride | Novartis |
| Trasitensine | Chlorthalidone; Oxprenolol Hydrochloride | Novartis |